Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’
oleh: Mike Bastian, Nick Freemantle, Ana B. Rossi, Brad Shumel, Gaelle Bego Le Bagousse, Zhixiao Wang, Yingxin Xu, Patricia Guyot
| Format: | Article |
|---|---|
| Diterbitkan: | Adis, Springer Healthcare 2024-02-01 |
Deskripsi
Subjek
Atopic dermatitis; Dupilumab; Eczema; Lebrikizumab; Matching-adjusted indirect comparison